DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Harper DM, Franco EL, Wheeler CM. et al.
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.
Lancet 2006;
367: 1247-1255
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.